REGASK SPEAKS AT APACMED TOWNHALL
In this session, RegASK’s CEO and product leaders showed how AI agents are transforming regulatory intelligence, impact assessment, workflow management, and decision-making across markets and what it means for the future of the RA profession.
Regulatory Affairs is entering a new era. AI agents are beginning to reshape how teams monitor change, assess impact, manage workflows, and support business decisions across markets.
This shift goes beyond efficiency. It points to a new operating model for Regulatory Affairs, where routine work becomes more automated, regulatory intelligence becomes more actionable, and regulatory professionals take on a more strategic role inside the business.
In this Lunch and Learn, we will explore how Agentic AI is changing regulatory workflows, reshaping the skills regulatory teams need, and helping companies prepare for a more intelligent, data driven, and proactive regulatory future.
Here’s what you can expect from this 1-hour session:
The key pressures facing regulatory teams today
What Agentic AI is and why it represents the next frontier of regulatory transformation
Real world use cases showing how Agentic AI can drive impact
How the role and skillsets of regulatory professionals are evolving
Practical steps regulatory leaders can take to prepare their teams
Experience the evolution from traditional regulatory affairs to intelligent regulatory leadership.
Founder & CEO, RegASK
Dr. Caroline Shleifer (PharmD, PhD) is the Founder and CEO of RegASK. Drawing on her experience across entrepreneurship, life sciences, and regulatory affairs, she founded RegASK to help organizations navigate increasing regulatory complexity through AI-powered intelligence.
Today, she works with global industry leaders to transform how regulatory, quality, and compliance teams operate in an era of accelerating change. A recognized thought leader in AI for regulatory compliance, Caroline regularly speaks on the responsible adoption of AI and the future of regulatory operations.
Chief Product and Technology Officer, RegASK
Amenallah Reghimi is the Chief Product & Technology Officer at RegASK, leading the development of the Agentic AI platform powering RegASK’s regulatory intelligence and workflow orchestration capabilities. At APACMed, he presented on the practical architecture of AI agents in regulatory operations and the roadmap to full agentic deployment in compliance teams.
Senior Regulatory Affairs Manager, RegASK
Patricia Teysseyre is a Senior Regulatory Affairs professional with over 20 years of experience in the medical devices industry across the US, Europe, and Asia Pacific. Her career spans EU MDR technical documentation, 510(k) submissions, regional regulatory planning, and cross-functional governance across medical devices and drug-device combination products. She currently serves as Senior Regulatory Affairs Manager and Project Lead at RegASK, a regulatory intelligence and consulting firm, where she leads investor-facing due diligence engagements and advises on regulatory strategy across FDA and EMA frameworks.
Book a demo to explore how RegASK automates regulatory surveillance, impact assessment, and compliance workflows across APAC and global markets.
